Clinitech Laboratory Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	92.39	82.35	64.03	63.48	63.84	45.54
Revenue Growth (YoY)	24.50%	28.61%	0.87%	-0.58%	40.19%	-
Cost of Revenue	24.97	18.81	13.78	14.14	18.18	13.1
Gross Profit	67.42	63.54	50.25	49.33	45.66	32.45
Selling, General & Admin	30.86	29.23	23.53	20.32	17.79	11.64
Other Operating Expenses	28.1	25.69	16.69	15.49	17.19	12.57
Operating Expenses	62.85	59.41	44.61	40.27	38.78	26.66
Operating Income	4.58	4.12	5.64	9.06	6.88	5.79
Interest Expense	-0.53	-0.43	-0.72	-0.58	-0.42	-0.75
Interest & Investment Income	1.3	1.3	0.1	0.08	0.06	0
Earnings From Equity Investments	-	-	-	0.04	0.11	0.01
Other Non Operating Income (Expenses)	0.44	-0.12	-0.07	0.04	0.4	0.11
EBT Excluding Unusual Items	5.78	4.87	4.95	8.64	7.02	5.16
Gain (Loss) on Sale of Investments	-	-	-	-	-	0.3
Gain (Loss) on Sale of Assets	0.68	0.68	0.11	-	-0	-
Pretax Income	6.46	5.55	5.05	8.64	7.02	5.46
Income Tax Expense	1.72	1.6	1.34	2.51	1.9	1.43
Net Income	4.74	3.95	3.71	6.13	5.13	4.02
Net Income to Common	4.74	3.95	3.71	6.13	5.13	4.02
Net Income Growth	-9.65%	6.33%	-39.45%	19.61%	27.39%	-
Shares Outstanding (Basic)	2	2	2	2	2	1
Shares Outstanding (Diluted)	2	2	2	2	2	1
Shares Change (YoY)	-	32.88%	4.44%	-	-	-
EPS (Basic)	1.97	1.90	2.37	4.09	3.42	2.68
EPS (Diluted)	1.97	1.90	2.37	4.09	3.42	2.68
EPS Growth	-	-19.98%	-42.03%	19.61%	27.39%	-
Free Cash Flow	-10.54	-20.43	-24.88	9.68	-5.58	1.87
Free Cash Flow Per Share	-4.38	-9.82	-15.88	6.45	-3.72	1.25
Gross Margin	72.98%	77.16%	78.47%	77.72%	71.52%	71.25%
Operating Margin	4.95%	5.01%	8.80%	14.27%	10.77%	12.71%
Profit Margin	5.13%	4.79%	5.80%	9.66%	8.03%	8.84%
Free Cash Flow Margin	-11.41%	-24.81%	-38.86%	15.24%	-8.73%	4.11%
EBITDA	8.46	8.62	9.97	13.52	10.69	8.24
EBITDA Margin	9.16%	10.47%	15.57%	21.30%	16.74%	18.10%
D&A For EBITDA	3.88	4.5	4.34	4.46	3.81	2.45
EBIT	4.58	4.12	5.64	9.06	6.88	5.79
EBIT Margin	4.95%	5.00%	8.80%	14.27%	10.77%	12.71%
Effective Tax Rate	26.62%	28.83%	26.52%	29.02%	27.00%	26.26%
Revenue as Reported	95.23	84.63	64.39	63.63	64.57	45.96
Advertising Expenses	-	0.62	0.65	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.